Evogene (EVGN) Tops Q2 EPS by 19c

Evogene (NASDAQ: EVGN) reported Q2 EPS of ($1.06), $0.19 better than the analyst estimate of ($1.25). Revenue for the quarter came in at $914 thousand versus the consensus estimate of $775 thousand.

For earnings history and earnings-related data on Evogene (EVGN) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Trifecta Gold closes $1.66M private placement for Yukon exploration
• Berenberg Starts Brooks Macdonald Group PLC (BRK:LN) at Buy